Sirnaomics

In News

Ningbo Polypeptide Technology Co., Ltd. announced that it has received funding from Sirnaomics Ltd. - marketscreener.com

marketscreener.com - Jun 29, 2026

Sirnaomics Completes Phase I Clinical Study of STP707 for Pancreatic Cancer with Strong Safety Profile and Promising Disease Stability - BioPharma APAC

BioPharma APAC - Aug 24, 2025

Sirnaomics Secures $105 Million in Series E Financing - PR Newswire

PR Newswire - Jul 01, 2021

Opening new frontiers in immuno-oncology with RNAi therapeutics - Nature

Nature - Sep 03, 2022

Sirnaomics gears up for Phase III isSCC trial - Clinical Trials Arena

Clinical Trials Arena - Jun 20, 2023

MoCo biopharma Sirnaomics raises another nine-figure round - The Business Journals

The Business Journals - Jul 06, 2021

Coronavirus: China tests AbbVie’s HIV drugs; Sirnaomics to develop drugs - pharmaceutical-technology.com

pharmaceutical-technology.com - Jan 27, 2020

Sirnaomics nabs a major $105M funding round for next stage of its RNA work - fiercebiotech.com

fiercebiotech.com - Oct 23, 2020

Clifford Chance advises Sirnaomics on its Chapter 18A Hong Kong IPO and listing - Clifford Chance

Clifford Chance - Dec 30, 2021

Sirnaomics Ltd. (2257.HK) company profile and facts - au.finance.yahoo.com

au.finance.yahoo.com - Oct 08, 2023

Sirnaomics: a unique, clinical-phase RNA therapeutic innovator on the global stage - Nature

Nature - May 16, 2022

Sirnaomics' Spin-Off RNAimmune Secures $10 Million Seed Financing to Advance its mRNA-Based Vaccine and Therapeutic Development - The Herald-Mail

The Herald-Mail - Apr 21, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment